Generation of non-permissive basement membranes by anti-laminin antibody fragments produced by matrix-embedded gene-modified cells

Cancer Immunology, Immunotherapy

Volumn 52, Issue 10, 2003, Pages 643-647

  Sanz, Laura ^a   Feijóo, Mónica ^a   Blanco, Belén ^a   Serrano, Antonio ^b   Álvarez Vallina, Luis ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Capillary morphogenesis; Extracellular matrix; Laminin; Single chain antibody fragments; Tumor plasticity

Indexed keywords

ANTIBODY; LAMININ ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PURIFICATION; ARTICLE; BASEMENT MEMBRANE; CANCER CELL; CAPILLARY; CELL ACTIVITY; CELL INTERACTION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MEMBRANE CHANNEL; MORPHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; TUMOR CELL;

BASEMENT MEMBRANE; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HUMANS; IMMUNOGLOBULIN FRAGMENTS; LAMININ; MICROSCOPY, CONFOCAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROTEOGLYCANS; TUMOR CELLS, CULTURED;

EID: 0142042500     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-003-0400-0     Document Type: Article

References (31)

1. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ (1992) HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99:683
2. Alitalo K, Carmeliet P (2002) Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1:219
3. Alvarez-Vallina L (2001) Genetic approaches for antigen-selective cell therapy. Curr Gene Ther 1:385
4. Bischoff J (1997) Cell adhesion and angiogenesis. J Clin Invest 100:S37
5. Bissell MJ, Radisky D (2001) Putting tumours in context. Nat Rev Cancer 1:46
6. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, Radmacher M, Simon R, Yakhini Z, Ben-Dor A, Sampas N, Dougherty E, Wang E, Marincola F, Gooden C, Lueders J, Glatfelter A, Pollock P, Carpten J, Gillanders E, Leja D, Dietrich K, Beaudry C, Berens M, Alberts D, Sondak V (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406:536
7. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249
8. Chang YS, di Tomaso E, McDonald DM, Jones R, Jain RK, Munn LL (2000) Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci USA 97:14608
9. Chester J, Ruchatz A, Gough M, Crittenden M, Chong H, Loic-Cosset F, Diaz RM, Harrington K, Alvarez-Vallina L, Vile R (2002) Tumor antigen-specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor-modified T cells. Nat Biotechnol 20:256
10. Colognato H, Yurchenco P (2000) Form and function: the laminin family of heterotrimers. Dev Dyn 218:213
11. Folberg R, Hendrix MJ, Maniotis AJ (2000) Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 156:361
12. Folkman J (1972) Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 175:40930.
13. Hawkins RE, Russell SJ, Winter G (1992) Selection of phage antibodies by binding affinity: mimicking affinity maturation. J Mol Biol 226:889
14. Hendrix MJ, Seftor EA, Meltzer PS, Gardner LM, Hess AR, Kirschmann DA, Schatteman GC, Seftor RE (2001) Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci USA 98:8018
15. Hendrix MJ, Seftor RE, Seftor EA, Gruman LM, Lee LM, Nickoloff BJ, Miele L, Sheriff DD, Schatteman GC (2002) Transendothelial function of human metastatic melanoma cells: role of the microenvironment in cell-fate determination. Cancer Res 62:665
16. Hoang MP, Selim MA, Bentley RC, Burchette JL, Shea CR (2001) CD34 expression in desmoplastic melanoma. J Cutan Pathol 28:508
17. Kobayashi H, Shirakawa K, Kawamoto S, Saga T, Sato N, Hiraga A, Watanabe I, Heike Y, Togashi K, Konishi J, Brechbiel MW, Wakasugi H (2002) Rapid accumulation and internalization of radiolabeled herceptin in an inflammatory breast cancer xenograft with vasculogenic mimicry predicted by the contrast-enhanced dynamic MRI with the macromolecular contrast agent G6-(1B4M-Gd)(256). Cancer Res 62:860
18. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, Meltzer PS, Hendrix MJ (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155:739
19. McDonald DM, Foss AJ (2000) Endothelial cells of tumor vessels: abnormal but not absent. Cancer Metastasis Rev 19:109
20. McDonald DM, Munn L, Jain RK (2000) Vasculogenic mimicry: how convincing, how novel, and how significant? Am J Pathol 156:383
21. Meyer GT, Matthias LJ, Noack L, Vadas MA, Gamble JR (1997) Lumen formation during angiogenesis in vitro involves phagocytic activity, formation and secretion of vacuoles, cell death, and capillary tube remodelling by different populations of endothelial cells. Anat Rec 249:327
22. Rusolahti E (2002) Specialization of tumour vasculature. Nat Rev Cancer 2:8321
23. Sanz L, Kristensen P, Russell SJ, Ramírez García JR, Álvarez-Vallina L (2001) Generation and characterization of recombinant human antibodies specific for native laminin epitopes: potential application in cancer therapy. Cancer Immunol Immunother 50:557
24. Sanz L, Kristensen P, Blanco B, Facteau S, Russell SJ, Winter G, Álvarez-Vallina L (2002) Single-chain antibody-based gene therapy: inhibition of tumor growth by in situ production of phage-derived human antibody fragments blocking functionally active sites of cell-associated matrices. Gene Ther 9:1049
25. Sanz L, Pascual M, Muñoz A, González MA, Hernández Salvador C, Álvarez-Vallina L (2002) Development of a computer-assisted high-throughput screening platform for anti-angiogenic screening. Microvasc Res 63:335
26. Satyamoorthy K, DeJesus E, Linnenbach AJ, Kraj B, Kornreich DL, Rendle S, Elder DE, Herlyn M (1997) Melanoma cell lines from different stages of progression and their biological and molecular analyses. Melanoma Res 7 [Suppl 2]:S35
27. Seftor RE, Seftor EA, Koshikawa N, Meltzer PS, Gardner LM, Bilban M, Stetler-Stevenson WG, Quaranta V, Hendrix MJ (2001) Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res 61:6322
28. Sharma N, Seftor RE, Seftor EA, Gruman LM, Heidger PM Jr, Cohen MB, Lubaroff DM, Hendrix MJ (2002) Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry. Prostate 50:189
29. Sood AK, Seftor EA, Fletcher MS, Gardner LM, Heidger PM, Buller RE, Seftor RE, Hendrix MJ (2001) Molecular determinants of ovarian cancer plasticity. Am J Pathol 158:1279
30. Timpl R (1996) Macromolecular organization of basement membranes. Curr Opin Cell Biol 8:618
31. Watson SA, Durrant LG, Morris DL (1990) The effect of the E2 prostaglandin enprostil, and the somatostatin analogue SMS 201 995, on the growth of a human gastric cell line, MKN45G. Int J Cancer 45:90